Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Cancer. 2022 Jan 5;128(7):1458–1466. doi: 10.1002/cncr.34079

Table 3.

Spearman’s rho and 95% Confidence Intervals (CI) to Assess Criterion Validity of Versions 1 and 2 DIGESTSafety and Overall DIGEST Grades with Reference Measures of Swallowing Function (n=1,331)

n SAFETY version 2 SAFETY version 1 DIGEST version 2 DIGEST version 1
r 95% CI r 95% CI r 95% CI r 95% CI
Sum of MBSImP items 1323 0.57 0.53 0.61 0.56 0.52 0.60 0.61 0.57 0.65 0.62 0.58 0.65
MDADI composite score at time of MBS 1175 −0.44 −0.49 −0.40 −0.45 −0.50 −0.40 −0.49 −0.53 −0.44 −0.49 −0.54 −0.45
Normalcy of diet (PSS-HN) 1323 −0.31 −0.36 −0.26 −0.29 −0.34 −0.24 −0.37 −0.42 −0.32 −0.37 −0.42 −0.32
Laryngeal elevation 1323 0.46 0.42 0.51 0.46 0.42 0.50 0.45 0.40 0.50 0.45 0.41 0.50
Anterior hyoid excursion 1323 0.25 0.20 0.30 0.24 0.19 0.29 0.26 0.21 0.31 0.27 0.21 0.32
Epiglottic movement 1323 0.51 0.46 0.56 0.49 0.44 0.53 0.50 0.46 0.55 0.50 0.45 0.54
Laryngeal vestibule closure 1323 0.58 0.54 0.62 0.58 0.54 0.62 0.55 0.51 0.59 0.55 0.51 0.59

Abbreviations: DIGEST, Dynamic Imaging Grade of Swallowing Toxicity; MBS, modified barium swallow; MBSImP, Modified Barium Swallow Impairment Profile; MDADI, MD Anderson Dysphagia Inventory; PSS-HN, Performance Status Scale for Head and Neck Cancer Patients. p <.0001 for all correlations; testing H0: r = 0. Analysis includes 1 MBS per patient.